InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: whatarush12 post# 15081

Tuesday, 03/14/2017 1:08:10 PM

Tuesday, March 14, 2017 1:08:10 PM

Post# of 74889
It's a Weak Buy according to Barchart. Forward sales projections are very dangerous with this company's antibiotic sales history.

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

@ $125 = $62,500,000 coming in 2017! wow

We are a SCREAMING BUY here people!!